Biphasic decay of cell-associated HIV-1 DNA in HIV-1-infected children on antiretroviral therapy

AIDS

Volumn 16, Issue 14, 2002, Pages 1961-1963

  De Rossi, Anita ^a   Walker, A Sarah ^b   De Forni, Davide ^a   Gibb, Diana M ^b  

^a AIDS Reference Center   (Italy)

^b MRC CLINICAL TRIALS UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; LAMIVUDINE; NELFINAVIR; PLACEBO; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ADOLESCENT; ARTICLE; CELL LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DOSE TIME EFFECT RELATION; DRUG EFFECT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LYMPHOCYTE COUNT; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS LOAD;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; PLASMA; RNA, VIRAL; VIRUS REPLICATION;

EID: 0037183864     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200209270-00015     Document Type: Article

References (8)

1. Paediatric European Network for Treatment of AIDS (PENTA). Comparison of dual nucleoside-analogue reverse-transcriptase inhibitor regimens with and without nelfinavir in children with HIV-1 who have not previously been treated: the PENTA 5 randomised trial. Lancet 2002, 359:733-740.
2. Ometto L, De Forni D, Patiri F, et al. Immune reconstitution in HIV-1-infected children on antiretroviral therapy: role of thymic output and viral fitness. AIDS 2002, 16:839-849.
3. Amemiya T. Regression analysis when the dependent variable is truncated normal. Econometrica 1973, 41:997-1016.
4. Huber PJ. The behaviour of maximum likelihood estimates under non-standard conditions. In: Proceedings of the 5th Berkeley Symposium on Mathematical Statistics and Probability. Berkeley, CA: University of California Press 1967, 1:221-233.
5. Galli M, Balotta C, Meroni L, et al. Early increase in cell-associated HIV-1 DNA in patients on highly active antiretroviral therapy. AIDS 1998, 12:2500-2502.
6. Siliciano JD, Siliciano RF. Latency and viral persistence in HIV-1 infection. J Clin Invest 2000, 106:823-825.
7. Cara A, Vargas J, Keller M, et al. Circular viral DNA and anomolous junction sequence in PBMC of HIV-infected individuals with no detectable plasma HIV RNA. Virology 2002, 292:1-5.
8. Gibb DM, Newberry A, Klein N, De Rossi A, Grosh-Woerner I, Babiker A. Immune repopulation after HAART in previously untreated HIV-1 infected children. Lancet 2000, 355:1331-1332.